News NeurologyLive, CMSC Offer Panel Series on Changes in MRI Guidelines for MS NeurologyLive, CMSC Offer Panel Series on Changes in MRI Guidelines for MS by Iqra Mumal, MSc | February 27, 2020 Share this article: Share article via email Copy article link NeurologyLive, a multimedia platform for specialists in that field, partnered with the Consortium of Multiple Sclerosis Centers (CMSC)Ā for its recent video series on changes inĀ magnetic resonance imaging (MRI) protocol and guidelines for treating and managingĀ multiple sclerosis (MS). This āPeer Exchangeā panel discussion includes four specialists in neurology and radiology, and is moderated by June Halper, MSN, and CEO of the CMSC. Talk covers protocol and guideline changes, as well as best ways for implementing them. The video series,Ā āUpdates to the MRI Protocol and Clinical Guidelines for MS: CMSC Working Group,ā is available for viewing online. āThe CMSC is proud to be an ongoing resource for all those affected by multiple sclerosis: the healthcare team and the patients and families who receive expert care, state-of-the-art education, and access to cutting-edge research,ā Halper said in a press release. Its five episodes start with discussion of the development of changes to the MRI protocol and guidelines in the context of the CMSC’s 2019 conference, and its alignment with the MAGNIMS protocol. Other episodes cover gadolinium as a contrast agent, the McDonald criteria, inflammatory activity in treatment decisions and modifications, and maintaining consistency and quality on MRI scans. The doctors also touch on their experiences in implementing these changes, and the need of cooperation across clinical, payor, and patient groups. Discussion also covers the CMSCās action plan. The four panel specialists are: Frederik Barkhof, MD, PhD, professor of neuroradiology at the Vrije Universiteit Medical Center Amsterdam David Li, MD, professor emeritus of radiology, and emeritus director of theĀ UBC MS/MRI Research Group at University of British ColumbiaĀ (UBC) Ā Scott D. Newsome, DO, Ā an associate professor of neurology atĀ Johns Hopkins MedicineĀ and director of its Neurosciences Consultation and Infusion Center Anthony Traboulsee, MD, a UBC professor and medical director of itsĀ Centre for Brain Health, and research chair forĀ MS Society of Canada āItās important that the neurology community be aware of changes to imaging and treatment protocols for MS,ā said Mike Hennessy Jr., president and CEO of MJH Life Sciences, the company that owns NeurologyLive. āNeurologyLive is proud to partner with the CMSC to help disseminate this important information to our audience of healthcare professionals,ā Hennessy added. People attending the 2020 ACTRIMS ForumĀ taking place through Saturday, Feb. 29, in West Palm Beach are invited to Ā stop at Booth #115 to learn more about this āPeer Exchange.ā Print This Page About the Author Iqra Mumal, MSc Iqra holds a MSc in Cellular and Molecular Medicine from the University of Ottawa in Ottawa, Canada. She also holds a BSc in Life Sciences from Queenās University in Kingston, Canada. Currently, she is completing a PhD in Laboratory Medicine and Pathobiology from the University of Toronto in Toronto, Canada. Her research has ranged from across various disease areas including Alzheimerās disease, myelodysplastic syndrome, bleeding disorders and rare pediatric brain tumors. Tags ACTRIMS 2020, CMSC, MRI, NeurologyLive
April 23, 2024 News by Margarida Maia, PhD AAN 2024: Subcutaneous Ocrevus led to nearly no relapses after year
April 22, 2024 News by Margarida Maia, PhD Viatris launches low-dose Copaxone generic formulation in Canada
April 22, 2024 News by Marisa Wexler, MS AAN 2024: Briumvi found to ease disability in certain MS patients